Trevi Therapeutics, Inc. TRVI Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s cash ratio?
- Trevi Therapeutics, Inc. (TRVI) reported cash ratio of 2.7× in Q1 2026.
- How has Trevi Therapeutics, Inc.'s cash ratio changed year-over-year?
- Trevi Therapeutics, Inc.'s cash ratio decreased by 3.3% year-over-year, from 2.8× to 2.7×.
- What is the long-term trend for Trevi Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s cash ratio has grown at a -24.9% compound annual growth rate (CAGR), from 8.1× to 1.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.